iMediSync QEEG case study
MCI: Alzheimer’s and Non-Alzheimer’s
Mild Cognitive Impairment is a intermediate stage between the brain’ s normal aging process and dementia. While the individual’s capacity to perform daily activities is maintained, cognitive functions including memory are decreased. Statistics show that 80% of people diagnosed with MCI will develop Alzheimer’s disease about six years after diagnosis. However, the morbidity between Alzheimer’s MCI and non-Alzheimer’s MCI is different, and this can be detected by the AI model based on QEEG learning. The graph demonstrates normal brain activity (yellow), compared to MCI (green) and Alzheimer’s Disease (blue). Similar comparisons can be established between healthy brain activities and depression, anxiety, ADHD, and several other neurological or psychiatric disorders.
MCI - Non Alzheimer’s
The Topomap Report shows that compared to a healthy brain, there is an increase of slow waves Theta and Alpha 1 in both temporal lobes. Simultaneously, Beta waves become more active in an effort to compensate for the slower EEG activity of Theta and Alpha 1 waves, during the early stages of Mild Cognitive Impairment. Patient is a 75-year-old female diagnosed with MCI.
MCI - Alzheimer’s Disease
The Topomap Report shows that compared to both a healthy brain and a non-Alzheimer’s MCI brain, there is a significant increase in Delta waves, which can be observed in the frontal lobe. At the same time, a great increase of slow waves Theta and Alpha 1 can also be observed in both temporal lobes, while Beta waves have decreased. These changes demonstrate the general decrease in EEG activity as MCI progresses. Patient is a 80-year-old male diagnosed with Alzheimer’s Disease.